AJJ Medtech Holdings Limited (SGX:584)

Market Cap	8.56M +42.3%
Revenue (ttm)	2.71M +6.1%
Net Income	-3.26M
EPS	-0.00
Shares Out	1.71B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000,100
Average Volume	9,448,855
Open	0.0050
Previous Close	0.0050
Day's Range	0.0040 - 0.0050
52-Week Range	0.0020 - 0.0120
Beta	0.50
RSI	33.68
Earnings Date	May 22, 2026

About AJJ Medtech Holdings

AJJ Medtech Holdings Limited, an investment holding company, provides integrated medical technology solutions for healthcare sector in Singapore. It develops, integrates, and sells complementary digital, artificial intelligence (AI), and robotics solutions. The company also offers Samsung Medison ultrasound medical devices and solutions for general imaging, women's health, and point-of-care applications; in-vitro diagnostics and life sciences, including point-of-care diagnostics equipment, such as blood glucose monitoring system and single-use ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 39
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 584

Financial Performance

In 2025, AJJ Medtech Holdings's revenue was 3.19 million, an increase of 37.41% compared to the previous year's 2.32 million. Losses were -2.93 million, -24.17% less than in 2024.